Multiple Sclerosis Clinical Trials in Philadelphia

Showing 281-300 of 358 trials

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

NCT00141297

PD-0332991 may work in cancer by stopping cancer cells from multiplying. PD-0332991 is in a new class of drugs called cyclin-dependent kinase (CDK inhibitors). This research study is the first time that PD-0332991 will be given to people. PD-0332991 is taken by mouth daily.

NeoplasmsLymphoma, Non-Hodgkin

Pfizer74 participantsStarted Sep 2004

Detroit, Michigan, United States • New York, New York, United States • Philadelphia, Pennsylvania, United States +1 more locations

TERMINATEDPHASE2< 1 mile

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

NCT00272181

The purpose of this study is to determine the safety, effectiveness, and recommended dose of Proxinium in North American patients with Squamous Cell Head and Neck Cancer

Squamous Cell Carcinoma of the Head and NeckCarcinoma, Squamous CellNeoplasms, Squamous Cell+3 more

Sesen Bio, Inc.15 participantsStarted Jan 2006

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +16 more locations

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

Multiple Sclerosis Trials in Other Cities

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

A Novel Prosocial Online Support Group for Distressed Breast Cancer Survivors

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

Study of Cetuximab in Combination With Tarceva in Patients With Solid Tumors

Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen

Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.

Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer

Safety and Tolerability of Glatiramer Acetate

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane

Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

BAY1238097, First in Man

Other Conditions in Philadelphia